These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 384128)

  • 1. Circulatory and platelet actions of 6,9-thiaprostacyclin (PGI2-S) in the cat.
    Lefer AM; Trachte GJ; Smith JB; Barnette WE; Nicolaou KC
    Life Sci; 1979 Jul; 25(3):259-63. PubMed ID: 384128
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilation produced by prostacyclin (PGI2) and 9(O)-thiaprostacyclin (PGI2-S) in the canine femoral circulation.
    Horii D; Kanayama T; Mori M; Shibasaki M; Ikegami S
    Eur J Pharmacol; 1978 Oct; 51(3):313-6. PubMed ID: 361420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
    Whittle BJ; Moncada S; Vane JR
    Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.
    Schrör K; Darius H; Matzky R; Ohlendorf R
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):252-5. PubMed ID: 6166877
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
    Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
    Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.
    Lefer AM; Ogletree ML; Smith JB; Silver MJ; Nicolaou KC; Barnette WE; Gasic GP
    Science; 1978 Apr; 200(4337):52-4. PubMed ID: 345441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
    Kauffman GL; Whittle BJ; Aures D; Grossman MI
    Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential actions of the prostaglandins on the pulmonary vascular bed.
    Kadowitz PJ; Spannhake EW; Levin JL; Hyman AL
    Adv Prostaglandin Thromboxane Res; 1980; 7():731-43. PubMed ID: 6989201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).
    Orchard MA; Ritter JM; Shepherd GL; Lewis PJ
    Br J Clin Pharmacol; 1983 May; 15(5):509-11. PubMed ID: 6344895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI; Saba SR; Blackburn CA; Hartmann RC; Mason RG
    Science; 1979 Aug; 205(4405):499-501. PubMed ID: 377493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of PGE2 and PGI2 in salt-loaded and salt-depleted dogs.
    Watson ML; Jones RL
    Adv Prostaglandin Thromboxane Res; 1980; 7():1057-60. PubMed ID: 6989176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.